DHR(Danaher Corporation) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $24.80B | $26.64B | $23.89B | $23.88B | $24.57B |
| 毛利润 | $15.24B | $16.19B | $14.03B | $14.21B | $14.52B |
| 营业利润 | $6.38B | $7.54B | $5.20B | $4.86B | $4.69B |
| 净利润 | $6.43B | $7.21B | $4.76B | $3.90B | $3.61B |
| 经营现金流 | $8.36B | $8.52B | $7.16B | $6.69B | $6.42B |
| 自由现金流 | $7.12B | $7.40B | $5.78B | $5.30B | $5.26B |
| 摊薄每股收益 | $8.61 | $9.66 | $6.38 | $5.29 | $5.05 |